NurExone Biologic Inc. (TSXV:NRX)
Canada · Delayed Price · Currency is CAD 0.4800
-0.0200 (-4.00%)
Oct 30, 2026, 3:19 PM EDT
NurExone Biologic Market Cap
NurExone Biologic has a market cap or net worth of CAD 46.27 million as of October 30, 2026. It is the 33,047th most valuable company in the world and the 950th biggest in Canada. Its market cap has decreased by 20.51% in one year.
Market Cap
46.27M
Enterprise Value
44.92M
Revenue
n/a
Global Rank
Country Rank
#950 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since June 23, 2022, NurExone Biologic's market cap has increased from 33.48M to 46.27M, an increase of 38.19%. That is a compound annual growth rate of 7.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 46.27M | -22.69% |
| Dec 31, 2025 | 59.85M | 36.16% |
| Dec 31, 2024 | 43.95M | 208.80% |
| Dec 28, 2023 | 14.23M | -14.84% |
| Dec 22, 2022 | 16.71M | -50.08% |
| Jun 23, 2022 | 33.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Helix BioPharma | 75.61M |
| Thiogenesis Therapeutics | 44.79M |
| Medicenna Therapeutics | 44.30M |
| Sharp Therapeutics | 43.26M |
| Sernova Biotherapeutics | 41.54M |
| BriaCell Therapeutics | 40.45M |
| Microbix Biosystems | 39.72M |
| MedMira | 35.09M |